VIMTALABS.BO stock down 17.10% on BSE 29 Jan 2026: watch support at INR 372.50
VIMTALABS.BO stock plunged 17.10% to INR 422.40 at market close on the BSE on 29 Jan 2026. The fall followed the 28 Jan earnings announcement and heavy selling, with volume at 22,601.00 shares versus an average of 12,802.00, giving a relative volume of 2.76. The move left the share well below its 50-day and 200-day averages at INR 594.66 and INR 595.00. In this top-losers briefing we explain the drivers, valuation metrics, technical levels and Meyka AI’s forecast outlook for Vimta Labs Limited (VIMTALABS.BO) in India
VIMTALABS.BO stock: market move and immediate drivers
The stock closed at INR 422.40, down INR 87.10 or 17.10% on the BSE (India) at market close. Trading showed a day low of INR 419.60 and day high of INR 465.80, with 22,601.00 shares traded. The decline followed the company’s earnings announcement on 28 Jan 2026 and higher-than-normal selling into the close, suggesting profit-taking and short-term re-pricing.
Earnings, valuation and company fundamentals for VIMTALABS.BO stock
Vimta Labs Limited reported trailing EPS of INR 16.61 and a reported PE of 27.55. Market capitalisation stands at INR 20,422,830,727.00 with 44,635,189 shares outstanding. Key ratios show a PB of 4.90 and price-to-sales of 5.31, while the current ratio is 3.30, indicating a sound short-term liquidity profile. These metrics point to premium valuation versus many healthcare peers.
Technical picture and levels to watch for VIMTALABS.BO stock
Technicals show weakness: RSI at 37.87, MACD negative and the stock trading well below its 50-day average INR 594.66. Immediate support sits near the 52-week low INR 372.50 and the day low INR 419.60. On the upside, short-covering could push resistance to the day high INR 465.80 and the 50-day average INR 594.66 if sentiment stabilises.
Meyka AI grade and VIMTALABS.BO stock forecast
Meyka AI rates VIMTALABS.BO with a score out of 100: 74.68/100 — Grade B+ — Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of INR 686.00 (implied upside 62.43%) and a 12-month target of INR 844.10 (implied upside 99.84%) versus the current INR 422.40. Forecasts are model-based projections and not guarantees.
Sector context and catalysts affecting VIMTALABS.BO stock
Vimta operates in Healthcare — Medical Diagnostics & Research. The sector has lagged broader markets recently, with peers showing mixed results. Key catalysts for VIMTALABS.BO stock include contract demand from pharma, margins in bioanalytical services, regulatory testing wins and quarterly results. Watch sector flow and large-cap healthcare moves as directional cues.
Risks, trading strategy and practical price targets
Downside risk includes earnings execution, client concentration and valuation reset; debt levels are low with debt-to-equity 0.02, which tempers leverage risk. For traders, a near-term defensive plan is to watch INR 372.50 as stop-risk and INR 465.80 as a first resistance. Analyst-style targets tied to Meyka forecasts: short-term target INR 580.29, 12-month target INR 844.10. Position sizing should reflect volatility and the stock’s recent volume spike.
Final Thoughts
VIMTALABS.BO stock recorded a sharp decline of 17.10% to INR 422.40 on the BSE at market close on 29 Jan 2026, driven by post-earnings selling and elevated volume (22,601.00). The drop leaves the share trading well below its 50-day average INR 594.66 and close to the 52-week low INR 372.50, signalling a short-term valuation reset. Meyka AI’s forecast model projects a monthly level of INR 686.00 (about 62.43% upside) and a 12-month projection of INR 844.10 (about 99.84% upside) compared with the current INR 422.40. These model-based targets set a bull case but carry execution and sector risk. Investors should weigh premium multiples (PE 27.55, PB 4.90) against strong liquidity (current ratio 3.30) and low leverage before adding exposure. Meyka AI, an AI-powered market analysis platform, flags this as a buy-graded stock with elevated near-term volatility, so use tight risk controls and monitor next quarter guidance and sector flows.
FAQs
Why did VIMTALABS.BO stock fall sharply on 29 Jan 2026?
VIMTALABS.BO stock fell 17.10% after the 28 Jan earnings announcement and heavy selling into the close. Volume was 22,601.00, above the 12,802.00 average, indicating significant distribution and short-term re-pricing.
What are the key support and resistance levels for VIMTALABS.BO stock?
Key support is the 52-week low at INR 372.50 and the day low INR 419.60. Immediate resistance sits at the day high INR 465.80 and the 50-day average INR 594.66.
What valuation metrics should investors watch for VIMTALABS.BO stock?
Watch PE at 27.55, PB at 4.90 and price-to-sales at 5.31. Also monitor EPS INR 16.61, current ratio 3.30, and dividend per share INR 1.00 for liquidity and payout context.
What price targets does Meyka AI set for VIMTALABS.BO stock?
Meyka AI’s model projects a monthly target of INR 686.00 (≈62.43% upside) and a 12-month target of INR 844.10 (≈99.84% upside). Forecasts are model-based and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
